Medigus Ltd. [NASDAQ: MDGS] loss -19.21% or -0.44 points to close at $1.85 with a heavy trading volume of 8495158 shares. The company report on December 2, 2020 that Medigus Prices $13 Million Underwritten Public Offering of ADSs.
Medigus Ltd. (Nasdaq, TASE: MDGS), a technology company engaged in advanced medical solutions and innovative internet technologies, announced the pricing of an underwritten public offering of 7,098,491 American Depositary Shares (the “ADSs”). Each ADS is being sold to the public at a price per ADS of $1.83. The gross proceeds to the Company from this offering are expected to be approximately $13 million before deducting underwriting discounts and commissions and other estimated offering expenses payable by the Company.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
The Company intends to use the net proceeds from this offering for working capital and general corporate purposes.
It opened the trading session at $1.88, the shares rose to $1.95 and dropped to $1.84, the range by which the price of stock traded the whole day. The daily chart for MDGS points out that the company has recorded -13.55% loss over the past six months. However, it is still -122.89% lower than its most recent low trading price.
If we look at the average trading volume of 5.43M shares, MDGS reached to a volume of 8495158 in the most recent trading day, which is why market watchdogs consider the stock to be active.
Here is what top equities market gurus are saying about Medigus Ltd. [MDGS]:
The Average True Range (ATR) for Medigus Ltd. is set at 0.43, with the Price to Sales ratio for MDGS stock in the period of the last 12 months amounting to 70.14. The Price to Book ratio for the last quarter was 1.16.
Trading performance analysis for MDGS stock
Medigus Ltd. [MDGS] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -46.84. With this latest performance, MDGS shares dropped by -22.59% in over the last four-week period, additionally sinking by -13.55% over the last 6 months – not to mention a rise of 2.78% in the past year of trading.
Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for MDGS stock in for the last two-week period is set at 42.48, with the RSI for the last a single of trading hit 35.29, and the three-weeks RSI is set at 44.43 for Medigus Ltd. [MDGS]. The present Moving Average for the last 50 days of trading for this stock 2.1256, while it was recorded at 2.6220 for the last single week of trading, and 1.8296 for the last 200 days.
Medigus Ltd. [MDGS]: A deeper dive into fundamental analysis
Operating Margin for any stock indicates how profitable investing would be, and Medigus Ltd. [MDGS] shares currently have an operating margin of -1537.73 and a Gross Margin at -66.67. Medigus Ltd.’s Net Margin is presently recorded at -5193.41.
Return on Total Capital for MDGS is now -50.88, given the latest momentum, and Return on Invested Capital for the company is -188.95. Return on Equity for this stock declined to -189.36, with Return on Assets sitting at -114.74. When it comes to the capital structure of this company, Medigus Ltd. [MDGS] has a Total Debt to Total Equity ratio set at 2.27. Additionally, MDGS Total Debt to Total Capital is recorded at 2.22, with Total Debt to Total Assets ending up at 1.14. Long-Term Debt to Equity for the company is recorded at 0.49, with the Long-Term Debt to Total Capital now at 0.48.
Reflecting on the efficiency of the workforce at the company, Medigus Ltd. [MDGS] managed to generate an average of -$2,525,815 per employee. Receivables Turnover for the company is 1.69 with a Total Asset Turnover recorded at a value of 0.02.
An analysis of insider ownership at Medigus Ltd. [MDGS]
There are presently around $1 million, or 9.91% of MDGS stock, in the hands of institutional investors. The top three institutional holders of MDGS stocks are: RENAISSANCE TECHNOLOGIES LLC with ownership of 189,071, which is approximately -47.872% of the company’s market cap and around 5.83% of the total institutional ownership; CITADEL ADVISORS LLC, holding 50,611 shares of the stock with an approximate value of $94000.0 in MDGS stocks shares; and VIRTU FINANCIAL LLC, currently with $50000.0 in MDGS stock with ownership of nearly New of the company’s market capitalization.
Positions in Medigus Ltd. stocks held by institutional investors increased at the end of December and at the time of the December reporting period, where 3 institutional holders increased their position in Medigus Ltd. [NASDAQ:MDGS] by around 80,283 shares. Additionally, 7 investors decreased positions by around 1,498,974 shares, while 0 investors held positions by with 1,295,603 shares. The mentioned changes placed institutional holdings at 283,654 shares, according to the latest SEC report filing. MDGS stock had 3 new institutional investments in for a total of 80,283 shares, while 4 institutional investors sold positions of 1,313,438 shares during the same period.